Lushang Freda Pharmaceutical Co.,Ltd.

SHSE:600223 Stock Report

Market Cap: CN¥7.1b

Lushang Freda PharmaceuticalLtd Valuation

Is 600223 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600223 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 600223 (CN¥6.84) is trading above our estimate of fair value (CN¥0.25)

Significantly Below Fair Value: 600223 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600223?

Key metric: As 600223 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600223. This is calculated by dividing 600223's market cap by their current earnings.
What is 600223's PE Ratio?
PE Ratio29.8x
EarningsCN¥236.52m
Market CapCN¥7.05b

Price to Earnings Ratio vs Peers

How does 600223's PE Ratio compare to its peers?

The above table shows the PE ratio for 600223 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average49.7x
000011 ShenZhen Properties & Resources Development (Group)
23.6xn/aCN¥5.2b
000863 Sanxiang Impression
130.1xn/aCN¥4.3b
600736 Suzhou New District Hi-Tech IndustrialLtd
39.4xn/aCN¥6.4b
000620 Macrolink Culturaltainment Development
5.5xn/aCN¥11.7b
600223 Lushang Freda PharmaceuticalLtd
29.4x27.4%CN¥7.1b

Price-To-Earnings vs Peers: 600223 is good value based on its Price-To-Earnings Ratio (29.4x) compared to the peer average (49.7x).

Price to Earnings Ratio vs Industry

How does 600223's PE Ratio compare vs other companies in the CN Real Estate Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
002147 Neoglory prosperity
1xn/aUS$100.99m
No more companies available in this PE range
600223 29.8xIndustry Avg. 47.5xNo. of Companies9PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 600223 is good value based on its Price-To-Earnings Ratio (29.4x) compared to the CN Real Estate industry average (47.5x).

Price to Earnings Ratio vs Fair Ratio

What is 600223's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600223 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.8x
Fair PE Ratio25x

Price-To-Earnings vs Fair Ratio: 600223 is expensive based on its Price-To-Earnings Ratio (29.4x) compared to the estimated Fair Price-To-Earnings Ratio (25x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600223 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥6.84
CN¥8.79
+28.5%
3.4%CN¥9.00CN¥8.28n/a4
Nov ’25CN¥6.75
CN¥9.25
+37.0%
9.6%CN¥10.70CN¥8.28n/a4
Oct ’25CN¥7.73
CN¥9.32
+20.5%
10.2%CN¥10.70CN¥8.07n/a4
Sep ’25CN¥6.31
CN¥9.32
+47.7%
10.2%CN¥10.70CN¥8.07n/a4
Aug ’25CN¥6.39
CN¥11.79
+84.4%
8.4%CN¥13.00CN¥10.70n/a4
Jul ’25CN¥7.03
CN¥11.79
+67.6%
8.4%CN¥13.00CN¥10.70n/a4
Jun ’25CN¥8.04
CN¥11.79
+46.6%
8.4%CN¥13.00CN¥10.70n/a4
May ’25CN¥7.89
CN¥11.79
+49.4%
8.4%CN¥13.00CN¥10.70n/a4
Apr ’25CN¥8.53
CN¥12.10
+41.9%
7.8%CN¥13.00CN¥10.80n/a3
Mar ’25CN¥9.02
CN¥12.10
+34.1%
7.8%CN¥13.00CN¥10.80n/a3
Feb ’25CN¥7.62
CN¥12.48
+63.8%
10.1%CN¥13.70CN¥10.74n/a3
Jan ’25CN¥9.63
CN¥12.48
+29.6%
10.1%CN¥13.70CN¥10.74n/a3
Dec ’24CN¥10.17
CN¥12.48
+22.7%
10.1%CN¥13.70CN¥10.74n/a3
Nov ’24CN¥10.46
CN¥12.48
+19.3%
10.1%CN¥13.70CN¥10.74CN¥6.753
Oct ’24CN¥8.90
CN¥12.44
+39.7%
10.6%CN¥13.70CN¥10.61CN¥7.733
Sep ’24CN¥8.99
CN¥12.94
+43.9%
11.1%CN¥14.43CN¥10.61CN¥6.314
Aug ’24CN¥10.39
CN¥13.15
+26.6%
8.3%CN¥14.43CN¥11.48CN¥6.394
Jul ’24CN¥10.26
CN¥13.71
+33.6%
4.3%CN¥14.43CN¥13.00CN¥7.033
Jun ’24CN¥10.04
CN¥13.42
+33.6%
5.3%CN¥14.43CN¥12.54CN¥8.044
May ’24CN¥10.96
CN¥13.42
+22.4%
5.3%CN¥14.43CN¥12.54CN¥7.894
Apr ’24CN¥10.59
CN¥13.42
+26.7%
5.3%CN¥14.43CN¥12.54CN¥8.534
Mar ’24CN¥11.71
CN¥12.51
+6.8%
12.0%CN¥14.43CN¥9.80CN¥9.025
Feb ’24CN¥11.28
CN¥12.03
+6.6%
10.8%CN¥13.00CN¥9.80CN¥7.624
Jan ’24CN¥10.59
CN¥12.03
+13.6%
10.8%CN¥13.00CN¥9.80CN¥9.634
Dec ’23CN¥10.71
CN¥11.71
+9.3%
11.5%CN¥12.78CN¥9.80CN¥10.173

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Beijing Urban Construction Investment & Development

CN¥11.7b

Beijing Urban Construction Investment & Development Co., Ltd.

600266

CN¥5.65

7D

-12.7%

1Y

-5.0%

Shenzhen Kingkey Smart Agriculture TimesLtd

CN¥8.5b

Engages in the real estate and breeding businesses in China.

48

CN¥16.20

7D

-5.6%

1Y

-10.6%

Gemdale

CN¥23.8b

Engages in the real estate development business in China and internationally.

600383

CN¥5.27

7D

-15.1%

1Y

-3.5%